Henry Kronenberg, MD is Chief of the Endocrine Unit at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School in Boston, MA. There he leads a research group that studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. Dr. Kronenberg's laboratory in recent years has used a number of genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone.
An active member of the Endocrine Society for more than two decades, he has served as Vice President, Basic Science, and as a member of the Society’s leadership Council. He also served on a number of Society committees, including the Laureate Awards Committee and Research Affairs Core Committee. Kronenberg has been an editorial board member for the Society’s basic science journals Endocrinology and Molecular Endocrinology. He represented the Society in work with the Federation of American Societies for Experimental Biology (FASEB). His awards and honors include the Society’s Gerald D. Aurbach Award Lecture, the International Research Prize from the Austrian Society for Bone and Mineral Research and the Neuman and Gideon Rodan Mentoring Awards from the American Society for Bone and Mineral Research (ASBMR). He has also served as President of the ASBMR and of the International Bone and Mineral Society.
Dr. Lynnette Nieman, MD is a Senior Investigator at the NIH Clinical Research Center and head of the Endocrine Consult service. She also directs the Office of Human Subjects Research Protections for intramural NIH. Dr. Nieman attended Smith College (A.B.) and SUNY Buffalo Medical School (M.D.). Her internal medicine residency and one year of endocrinology fellowship were done at SUNY Buffalo. In 1982 she joined the NIH as an endocrinology fellow. From 1991 to 2001 she served as the Clinical Director of intramural NICHD, overseeing the clinical care of the institute’s patients and ensuring compliance with human subjects research regulations. Dr. Nieman is an active clinical investigator, with eleven active protocols and special expertise in disorders of hypercortisolism. She has authored more than 250 publications and sponsored three investigational new drug applications, one of which was licensed in the US and Europe. Dr. Nieman served as an associate editor for the Journal of Clinical Endocrinology and Metabolism and is a past member of the Endocrinology and Metabolism subcommittee of the American Board of Internal Medicine. She has received the NIH Director’s Award, NIH Clinical Teacher of the Year Award and the Endocrine Society’s Distinguished Physician award. She has provided Congressional testimony. She is a past Vice President for Clinical Science of the Endocrine Society and Chaired the Society’s 2012 annual meeting. Dr. Nieman is currently the President-elect Designate of the Endocrine Society.
Lisa Fish, MD is a faculty member in the Division of Endocrinology and Medical Director of the Diabetes and Endocrinology Clinic at Hennepin County Medical Center in Minneapolis, MN. She also is Assistant Professor of Medicine at the University of Minnesota Medical Center. Dr. Fish is an influential and active leader in clinical endocrinology. Her interests include diabetes, osteoporosis, thyroid and adrenal disease in pregnancy, and hormone abuse. An active member of the Society for more than two decades, she has served as Vice President, Physician-in-Practice, and as a member of the Society’s Council. She served on the Society’s Advocacy and Public Outreach Core Committee and chaired the precursor to the Society’s Hormone Health Network. Dr. Fish has represented the Society in work with organizations such as the U.S. Preventative Services Task Force, the American Medical Association and the American Diabetes Association. She has received numerous honors and awards, including the Society’s Distinguished Physician Award and Sidney H. Ingbar Distinguished Service Award.
Richard S. Legro, MD is a Professor in the Department of Obstetrics and Gynecology and Public Health at Pennsylvania State University College of Medicine in Hershey, PA. His research and clinical practice are primarily focused on diagnosis, treatment, and genetic and environmental causes of polycystic ovary syndrome (PCOS), as well as improving infertility diagnosis and treatment. At Penn State Hershey Medical Center, he established one of the first clinics devoted to the treatment of women with PCOS. Dr. Legro has published over 200 articles in peer-reviewed journals and multiple books in the field of reproductive endocrinology, is an Associate Editor for Fertility and Sterility, and is Co-editor in Chief of Seminars in Reproductive Endocrinology. Dr. Legro has been a member of the Endocrine Society since 1998 and has served on the Clinical Guidelines Subcommittee, the Finance and Audit Committee, and the Performance and Compensation Steering Committee.
Carol A. Lange, PhD is a Professor in the Departments of Medicine and Pharmacology at the University of Minnesota. She has served on several NIH Study Sections including Molecular Oncogenesis (MONC) and Molecular and Cellular Endocrinology (MCE), where she is currently a standing member. Dr. Lange studies the molecular biology of breast cancer. Her laboratory is focused on the study of cross-talk between mitogenic protein kinases active downstream of peptide growth factors and steroid hormone receptors in human breast cancer models, with the goal of developing better strategies for the treatment of breast and other hormonally influenced and/or epithelial cell-derived cancers. Dr. Lange has been a member of the Endocrine Society since 1999 and has served as Editor-in-Chief of Hormones and Cancer (she is currently an Editorial Board Member), the Annual Meeting Steering Committee, and the Laureate Awards Committee.
Howard Baum, MD started his career as a researcher in neuroendocrinology, focusing on growth hormone and IGF-I, but patient care held a greater allure. In 1996, he entered private practice in general endocrinology. During that time, he began his involvement with Endocrine Society governance, bringing the perspective of a clinician to the Clinical Affairs and Scientific and Educational Core Committees and Council. He also participated in teaching programs at UT Southwestern Medical Center as a Clinical Professor. In 2012, Dr. Baum returned to academia, joining the faculty of Vanderbilt University Medical Center where he currently serves as Associate Professor in the Division of Endocrinology. He is Program Leader of the Diabetes and Obesity Clinical Trials Center, Co-Director of the inpatient endocrinology consultation service, and faculty development representative for the junior faculty in the Division. A member since 1996, Dr. Baum has served on the Strategic Planning Committee and several Endocrine Society Task Forces.
Anthony McCall, MD, PhD is a Professor of Medicine in the Division of Diabetes and Metabolism at the University of Virginia (UVA) School of Medicine. He also heads the Clinical Diabetes services at the UVA Health System. In addition, Dr. McCall serves as Medical Director at the Virginia Center for Diabetes Professional Education and the Diabetes Education and Management Program of the UVA Health System. Prior to joining UVA, Dr. McCall was Professor of Medicine at the Oregon Health Sciences University, where he served as Director of Diabetes Research, Director of the VA lipid clinic, and the Co-Director of the High Risk Diabetes clinic. His current clinical research addresses the use of insulin infusions to achieve tight glycemic control with low hypoglycemic risk in patients with cardiovascular surgery and separately work on glucagon dynamics in people at risk for type 1 diabetes. Dr. McCall has been a member of the Endocrine Society since 1984 and has served on the Special Programs Committee and the Annual Meeting Steering Committee.
Bradley D. Anawalt, MD is the Chief of Medicine at the University of Washington Medical Center and Professor and Vice Chair of the Department of Medicine at the University of Washington. Dr. Anawalt's teaching has been recognized with the Paul Beeson teaching award and the endocrine-fellowship teaching award at the University of Washington. He serves as a consultant to the United States Anti-Doping Agency, on the editorial board of Endocrine Reviews and as the North American Editor of Clinical Endocrinology. He has done research in male infertility, male hormonal contraception and the male reproductive physiology. An Endocrine Society member since 1997, Dr. Anawalt has served on the Journal of Clinical Endocrinology and Metabolism Editorial Board, the Annual Meeting Steering Committee, the Special Programs Committee, and has chaired the Hormone Health Network Committee.
Beverly M.K. Biller, M.D. is a faculty member of the Neuroendocrine Unit at The Massachusetts General Hospital, Boston, Massachusetts, and is Professor of Medicine at Harvard Medical School. Dr. Biller has had a longstanding interest in the diagnosis and treatment of pituitary tumors, with a special interest in Cushing’s disease and treatment of growth hormone deficiency in adults, and has published both primary scientific research and clinical guidelines on these topics. She has served as President of the Association of Program Directors of Endocrinology and Metabolism (APDEM) and on the Council of the Growth Hormone Research Society. Dr. Biller has been a member of the Endocrine Society since 1990 and has served as an Associate Editor of the Journal of Clinical Endocrinology and Metabolism, as Chair of the Annual Meeting Steering Committee and as Chair of the Scientific and Educational Programs Core Committee, and has been a member of the Laureate Awards Committee and the Nominating Committee. She serves as Council Liaison to the Endocrine Society Committee on Diversity and Inclusion.
Alan Dalkin, MD is a professor of medicine in the Division of Endocrinology and Metabolism and is the Vice Chairman for the Department of Medicine at the University of Virginia. In addition to being a clinical educator, he treats patients with a wide variety of endocrine disorders and is an expert in disorders of the bone and mineral. Dr. Dalkin has served as program director of the Endocrine Fellowship Program and is a former chief of the Division of Endocrinology. He serves on the Residency Review Committee, the body that oversees credentialing of all residency and fellowship programs in the United States. Dr. Dalkin has been a member of the Endocrine Society since 1989. He was a member of the ESAP Faculty Group from 2000 to 2011 and chaired the group from 2011-2015.
Guillermo Enrique Umpierrez, MD is Professor of Medicine in the Division of Endocrinology, Metabolism at Emory University School of Medicine, and Chief of Diabetes and Endocrinology at Grady Memorial Hospital. His research interests include mechanisms for ß-cell dysfunction in minority populations with ketosis-prone type 2 diabetes and the inpatient management of hyperglycemia and diabetes in critical and non-critical patients. Dr. Umpierrez heads the Emory Latino Diabetes Education Program (ELDEP), the first nationally accredited, all-Spanish Diabetes education program dedicated to providing diabetes education and lifestyle intervention to Latinos in Georgia. Dr. Umpierrez has been a member of the Endocrine Society since 1993 and has served on the Hormone Health Network Committee, Clinical Guidelines Subcommittee, the Clinical Endocrinology Update Committee, the JCEM Editorial Board, Special Programs Committee, and Chair of the Global Task Force.
Dr. Carol Hatch Wysham is the Section Head of The Rockwood Center for Diabetes and Endocrinology at Rockwood Clinic in Spokane, WA. She is also Clinical Associate Professor of Medicine in the School of Medicine, University of Washington. Dr. Wysham has been involved in clinical research throughout her career. She has served as the principal investigator for several large-scale clinical trials related to diabetes and its complications/treatments. A member of the Endocrine Society since 1991, she has served as the Chair of the Professional Practice Committee of the ADA (2011, 2012), as co-chair of the ICE/ENDO 2014 and ENDO 2015 Annual Meetings, is Overall Chair of ENDO 2016. She is the recipient of the O.C. Olson Lectureship award (1996), and the Chairman’s Quality Award (2011, 2015).
Genevieve S. Neal-Perry MD, PhD is an Associate Professor of Obstetrics and Gynecology. She directs the University of Washington Medicine Reproductive Endocrinology and Infertility Center. She has expertise in the treatment of infertility, fertility preservation, recurrent pregnancy loss and the development of procreative management plans for same sex couples and single parents. She is also a leader in the area of medical management of menopause, polycystic ovary syndrome (PCOS), premature loss of ovarian function and other endocrine disorders that affect the function of the hypothalamic-pituitary ovarian axis. Dr. Neal-Perry conducts human and rodent research that is focused on understanding nutritional and environmental factors that affect the age of puberty, ovarian and testicular function, fertility and the age of menopause. She is especially interested in the effect of maternal or paternal environment on fertility of male and female offspring across multiple generations. Dr. Neal-Perry has been a member of the Endocrine Society since 2001 and has served on the Special Programs Committee, the Research Affairs Core Committee, and the ENDO Editorial Board.
Daniel Bernard, PhD is a Professor of Pharmacology and Therapeutics and Director of the McGill University Centre for Research in Reproduction and Development. He is also an associate member of the McGill Departments of Physiology, Anatomy and Cell Biology, and Obstetrics and Gynecology, and is a member of the Division of Endocrinology and Metabolism and the Integrated Program in Neuroscience. The Bernard lab investigates molecular mechanisms of pituitary hormone synthesis using in vitro and in vivo approaches. Dr. Bernard has been a member of the Endocrine Society since 2003 and has served on the ENDO and MEND Editorial Boards, the Research Affairs Core Committee, and the Scientific and Educational Programs Core Committee. He has also served on the Advisory Panel on International Outreach, the ENDO Phase I & II Task Forces, the Basic Science Task Force, and the NextGen Task Force. Dr. Bernard is also the Endocrine Society representative on the Science Policy Committee of the Federation of American Societies for Experimental Biology.
R. Michael Tuttle, MD is a professor of medicine at the Joan and Sanford I. Weill Medical College of Cornell University who specializes in advanced thyroid cancer. Dr. Tuttle treats patients at Memorial Sloan Kettering and is actively researching new treatments for advanced thyroid cancer. His research projects in radiation-induced thyroid cancer have taken him around the world, from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. Dr. Tuttle has been a member of the Endocrine Society since 1993 and has served on the Clinical Endocrine Education Committee, the JCEM Editorial Board, and the Annual Meeting Steering Committee (as a member and as the Clinical Science Chair).
Lauren Fishbein, MD, PhD is an Assistant Professor in Medicine at the University of Colorado School of Medicine in the Division of Endocrinology, Metabolism and Diabetes. She received her bachelor’s degree in Biochemistry from Vassar College and earned her MD, PhD degree from the University of Florida with a PhD in Molecular Genetics. She completed her Internal Medicine Residency at Beth Israel Deaconess Medical Center in Boston and her Endocrinology Fellowship at the University of Pennsylvania. Her research interests are in neuroendocrine tumor genetics with a focus on pheochromocytomas and paragangliomas. Dr. Fishbein has been a member of the Endocrine Society since 2010, and she currently serves as Co-Chair of the Trainee and Career Development Core Committee (TCDCC). As a member of the TCDCC, she was program chair of the Early Career Forum and Career Development Workshops for three years.
Kathryn Martin, MD is an Assistant Professor of Medicine at Harvard Medical School and has been a faculty member and practicing clinician in the Reproductive Endocrine Unit at Massachusetts General Hospital since 1989. In addition to her clinical practice, she has an active teaching role and is involved in the training and supervision of junior faculty members and endocrine fellows. Dr. Martin is also the Senior Deputy Editor for Endocrinology and Patient Education at UpToDate, an online clinical reference for physicians. Her clinical research interests have been in the area of female reproduction, in particular, pathophysiology and management of isolated GnRH deficiency and hypothalamic amenorrhea. Her current clinical focus is female reproduction; she has written and lectured extensively on her particular area of expertise: evaluation and management of menopausal women. Dr. Martin has been active in a number of Endocrine Society committees, and recently completed four years as the Chair of the Clinical Guidelines Subcommittee. She is also the Chair of the Task Force and first author of the Clinical Guideline: Evaluation and Treatment of Hirsutism in Premenopausal Women, first published in 2008, and recently revised and submitted for review. She is currently a member of the Nominating Committee and will serve as its Chair in 2016-2017.
Barbara Byrd Keenan, FASAE, CAEjoined the Endocrine Society as CEO in 2014. Prior to joining the Endocrine Society, Ms. Keenan was the Executive Vice President/CEO of the Institute of Food Technologists and Feeding Tomorrow as well as staff head of the International Food Science Certification Commission. During her decade plus tenure there, the Institute won over 25 awards for education, publishing, advocacy, marketing, design and scientific achievement. 2016 marks her 40th year of association management experience and 30 years of CEO experience, having previously served as CEO with the Hospitality Financial and Technology Professionals International and Community Associations Institute. She also has held senior positions and consulting relationships with the American College of Preventive Medicine, the American College of Cardiology and the American Association of Neurological Surgeons. She is the recipient of the ASAE Key Award — the highest honor in association management and is the 12th woman to receive it since its creation in 1960. She holds a BS and MS degree from Old Dominion University in Virginia, where she was presented with the Distinguished Alumni Award.